01722756344

Department Of Hepatology

PGI Chandigarh

  • Sahu SK, Chawla YK, Dhiman RK, Singh V, Duseja A, Taneja S, Kalra N, Gorsi U. Rupture of Hepatocellular Carcinoma: A Review of Literature. J Clin Exp Hepatol. 2019 Mar-Apr;9(2):245-256.
  • Devarbhavi H, Choudhury AK, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Chawla YK, Dhiman RK, Duseja A, Taneja S, Ning Q, Jia JD, Duan Z, Yu C, Eapen CE, Goel A, Tan SS, Hamid SS, Butt AS, Jafri W, Kim DJ, Hu J, Sood A, Midha V, Shukla A, Ghazinian H, Sahu MK, Treeprasertsuk S, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Kalal C, Abbas Z, Sollano JD, Prasad VGM, Payawal DA, Dokmeci AK, Rao PN, Shrestha A, Lau GK, Yuen MF, Saraswat VA, Shiha G, Yokosuka O, Kedarisetty CK, Jain P, Bhatia P, Sarin SK; APASL ACLF working party. Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients. Am J Gastroenterol. 2019 Apr 22.
  • Dhiman RK, Grover GS, Premkumar M, Taneja S, Duseja A, Rathi S, Satsangi S. Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective. J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):74-80
  • Roy A, Taneja S. Type of organ failure and acute insult have important bearings in outcomes of liver transplantation: A pragmatic discourse. J Hepatol. 2018 Nov 3. pii: S0168-8278(18)32384-5.
  • Verma N, Singh S, Taneja S, Duseja A, Singh V, Dhiman RK, Chakrabarti A, Chawla YK. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections. Liver Int. 2018 Oct 1. [Epub ahead of print]
  • Sahu SK, Taneja S, Kalra N, Dhiman RK, Chawla YK, Duseja A, Singh V. Rupture of Hepatocellular Carcinoma: a Tale of 20 Cases from a Tertiary Care Center in Northern India. J Gastrointest Cancer. 2018 Feb 4.
  • Taneja S, Duseja A, De A, Kumar V, Ramachandran R, Sharma A, Dhiman RK, Gupta KL, Chawla Y. Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients. Nephrology (Carlton). 2018;23:876-882.
  • Dhiman RK, Grover GS, Premkumar M, Taneja S, Duseja A, Rathi S, Satsangi S. Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective. J Pediatr Gastroenterol Nutr. 2018 Sep 11.
  • Anand L, Choudhury A, Bihari C, Sharma BC, Kumar M, Maiwall R, Tan SS, Shah SR, Hamid S, Butt AS, Jafri W, Chawla YK, Taneja S, Duseja A, Dhiman RK, Mahtab MA, Ghazinyan H, Duan Z, Chen Y, Shukla A, Hu J, Abbas Z, Treeprasertsuk S, Lesmana LA, Lesmana CR, Sollano JD, Carpio G, Sahu MK, Kumar G, Sarin SK; APASL ACLF (AARC) working party. Flare of Autoimmune Hepatitis causing acute on chronic liver failure (ACLF): diagnosis and response to corticosteroid therapy. Hepatology. 2018 Aug 16.
  • Satsangi S, Duseja A, Sachdeva M, Tomer S, Arora SK, Taneja S, Dhiman RK, Chawla YK. Monocyte human leukocyte antigen - Antigen D related, neutrophil oxidative burst and cytokine analysis in patients of decompensated cirrhosis with and without acute-on chronic liver failure. PLoS One. 2018;13:e0200644.
  • Taneja S, Kumar P, Mitra S, Duseja A, Minz R, Das A, Dhiman RK, Chawla Y. Acute Exacerbation to Autoimmune Hepatitis Mimicking Acute Viral Hepatitis-A Case Series and Review of Literature. J Clin Exp Hepatol. 2018;8:98-103.
  • Taneja S, Duseja A, De A, Mehta M, Ramachandran R, Kumar V, Kohli HS, Gupta KL, Dhiman RK, Chawla Y. Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease. Dig Dis Sci. 2018;63:1334-1340.
  • Ramachandran R, Yadav AK, Kumar V, Varma A, Taneja S, Nada R, Gupta KL, Jha V. PLA2R related primary membranous nephropathy in a hepatitis C positive patient. Nephrology (Carlton). 2018;23:288.
  • Verma N, Kumar P, Mitra S, Taneja S, Dhooria S, Das A, Duseja A, Dhiman RK, Chawla Y. Drug idiosyncrasy due to pirfenidone presenting as acute liver failure: Case report and mini-review of the literature. Hepatol Commun. 2017;2:142-147.
  • Rathi S, Taneja S. Terminating and episode of overt hepatic encephalopathy: L-ornithine-L-aspartate may have some role. Hepatology. 2017 Oct 10. [Epub ahead of print]
  • Taneja S, Borkakoty A, Rathi S, Kumar V, Duseja A, Dhiman RK, Gupta KL, Chawla Y. Assessment of Liver Fibrosis by Transient Elastography Should Be Done After Hemodialysis in End Stage Renal Disease Patients with Liver Disease. Dig Dis Sci. 2017;62:3186-3192.
  • Kumar P, Taneja S, Singh V. Beta-blockers in patients with advanced liver disease: Has the dust settled? Liver Transpl. 2017;23:1351-1352.
  • Kumar P, Taneja S, Singh V. Does the dose and type of nonselective beta-blocker really matter? Hepatology. 2017;66:301-302.
  • Gupta T, Dhiman RK, Ahuja CK, Agrawal S, Chopra M, Kalra N, Duseja A, Taneja S, Khandelwal N, Chawla Y. Characterization of Cerebral Edema in Acute-on-Chronic Liver Failure. J Clin Exp Hepatol. 2017;7:190-197.
  • Choudhury A, Jindal A, Maiwall R, Sharma MK, Sharma BC, Pamecha V, Mahtab M, Rahman S, Chawla YK, Taneja S, Tan SS, Devarbhavi H, Duan Z, Yu C, Ning Q, Jia JD, Amarapurkar D, Eapen CE, Goel A, Hamid SS, Butt AS, Jafri W, Kim DJ, Ghazinian H, Lee GH, Sood A, Lesmana LA, Abbas Z, Shiha G, Payawal DA, Dokmeci AK, Sollano JD, Carpio G, Lau GK, Karim F, Rao PN, Moreau R, Jain P, Bhatia P, Kumar G, Sarin SK; APASL ACLF Working Party. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models. Hepatol Int. 2017 Aug 30. [Epub ahead of print]
  • Taneja S, Kumar P, Rathi S, Duseja A, Singh V, Dhiman RK, Chawla YK. Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment. Ann Hepatol. 2017;16:818-821.
  • Verma N, Sharma M, Biswal M, Taneja S, Batra N, Kumar A, Dhiman RK. Hepatitis E Virus Induced Acute Liver Failure with Scrub Typhus Coinfection in a Pregnant Woman. J Clin Exp Hepatol. 2017;7:158-160
  • Mehta M, Satsangi S, Duseja A, Taneja S, Dhiman RK, Chawla Y. Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? J Clin Exp Hepatol. 2017;7:121-126.
  • Taneja S, Kumar P, Gautam V, Duseja A, Singh V, Dhiman RK, Chawla Y. Spontaneous Bacterial Peritonitis by Burkholderia cepacia Complex: A Rare, Difficult to Treat Infection in Decompensated Cirrhotic Patients. J Clin Exp Hepatol. 2017;7:102-106.
  • Taneja S, Chawla YK. Perioperative use of terlipressin in adult liver transplant. Liver Transpl. 2017;23:995-996.
  • Kumar P, Taneja S, Gupta K, Duseja A, Dhiman RK, Chawla YK. Unusual Presentation of Tubercular Liver Abscess in an Immune-Competent Adult. J Clin Exp Hepatol. 2017;7:77-79.
  • Gupta T, Dhiman RK, Rathi S, Agrawal S, Duseja A, Taneja S, Chawla Y. Impact of Hepatic and Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure. J Clin Exp Hepatol. 2017;7:9-15.
  • Satsangi S, Mehta M, Duseja A, Taneja S, Dhiman RK, Chawla Y. Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with Pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C. J Gastroenterol Hepatol. 2017;32:859-863.
  • Borkakoty A, Kumar P, Taneja S. Hepatic Encephalopathy. N Engl J Med. 2017;12;376:186.
  • Taneja S, Tohra S, Duseja A, Dhiman RK, Chawla YK. Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital. J Clin Exp Hepatol. 2016;6:282-290.
  • Kumar P, Taneja S, Singh V. Treatment of Patients with Cirrhosis. N Engl J Med. 2016;375:2102-3.
  • Taneja S, Kumar P, Duseja A, Singh V, Dhiman RK, Chawla Y. Honeycomb Cyst of the Liver. J Clin Exp Hepatol. 2016;6:250-251.
  • Taneja S, Borakokty A, Duseja A, Dhiman RK, Chawla Y. Acute Liver Failure Caused by Hepatitis A Virus with Dengue Coinfection. J Clin Exp Hepatol. 2016;6:164.
  • Taneja S, Sakpal M, Ranjan R, Duseja A, Dhiman PK, Chawla YK. Hepatology: Hepato splenic sarcoidosis presenting as cholestatic jaundice and severe constitutional symptoms mimicking malignancy. J Gastroenterol Hepatol. 2015;30:968.
  • Prabhakar N, Vyas S, Taneja S, Khandelwal N. Intrahepatic aneurysmal portohepatic venous shunt: what should be done? Ann Hepatol. 2015;14:118-20.
  • Gupta S, Taneja S. Liver transplantation for portal cavernoma cholangiopathy. J Clin Exp Hepatol. 2014;4(Suppl 1):S85-7.
  • Dhiman RK, Saraswat VA, Valla DC, Chawla Y, Behera A, Varma V, Agarwal S, Duseja A, Puri P, Kalra N, Rameshbabu CS, Bhatia V, Sharma M, Kumar M, Gupta S, Taneja S, Kaman L, Zargar SA, Nundy S, Singh SP, Acharya SK, Dilawari JB. Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver. J Clin Exp Hepatol. 2014;4(Suppl 1):S2-S14.
  • Taneja S, Wadhawan M, Gupta S, Goyal N, Ramaswamy KV, Chaudhary A. Congenital hepatic fibrosis with extra-hepatic porto-systemic shunt and hepatopulmonary syndrome successfully managed with living related liver transplantation. Trop Gastroenterol. 2014;35:116-8.
  • Taneja S, Gupta S, Wadhawan M, Goyal N. Single-lobe living donor liver transplant in a morbidly obese cirrhotic patient preceded by laparoscopic sleeve gastrectomy. Case Rep Transplant. 2013;2013:279651.
  • Wadhawan M, Gupta S, Goyal N, Taneja S, Kumar A. Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis. Liver Transpl. 2013;19:1030-5.
  • Wadhawan M, Kumar A, Gupta S, Goyal N, Shandil R, Taneja S, Sibal A. Post-transplant biliary complications: an analysis from a predominantly living donor liver transplant center. J Gastroenterol Hepatol. 2013;28:1056-60.
  • Taneja S, Chawla Y, Dhiman RK. Noncirrhotic portal fibrosis: a rare cause of end-stage liver disease requiring liver transplantation. Hepatol Int. 2013;7:313-5.
  • Gupta S, Taneja S, Duseja A, Dhiman RK, Chawla Y, Kalra N, ArunanshuBehera. Giant hydatid cyst of the liver. Tropical Gastroenterology 2013;34:112–113
  • Taneja S, Dhiman RK, Khatri A, Goyal S, Thumbru KK, Agarwal R, Duseja A, Chawla Y. Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver. J Clin Exp Hepatol. 2012;2:306-14.
  • Thumburu KK, Taneja S, Vasishta RK, Dhiman RK. Neuropathology of acute liver failure. Neurochem Int. 2012;60:672-5.
  • Taneja SK, Dhiman RK. Prevention and management of bacterial infections in cirrhosis. Int J Hepatol. 2011;2011:784540.
  • Tohra SK, Taneja S, Ghosh S, Sharma BK, Duseja A, Dhiman RK, Das A, Chawla YK. Prediction of sustained virological response to combination therapy with pegylated interferon alfa and ribavirin in patients with genotype 3 chronic hepatitis C. Dig Dis Sci. 2011;56:2449-55.
  • Taneja S, Kalra N, Dhiman RK, Chawla YK. An abnormal portal vein. Liver Int. 2011;31:65.
  • Taneja S, Sharma A, Duseja A, Kalra N, Dhiman RK, Chawla Y. Spontaneous perforation of gallbladder with intrahepatic bilioma. Journal of Clinical and Experimental Hepatology 2011.1(3) Dec 210-211
  • Taneja S, Chawla Y, Dhiman RK. Noncirrhotic portal fibrosis: a rare cause of end-stage liver disease requiring liver transplantation. Hepatol Int. 2011 Sep 3. Epub ahead of print
  • Wadhawan M, Kumar A, Taneja S. Biliary complications after liver transplant. Indian journal of organ transplantation.2011;5:96-101
  • Taneja S, Dhiman RK. Non Cirrhotic Portal Fibrosis and Gamma Gandy bodies. Journal of Clinical and Experimental Hepatology 2011;1:48
  • Duseja A, Chawla YK, Dhiman RK, Kumar A, Choudhary N, Taneja S. Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure (ACLF). Dig Dis Sci. 2010;55:3188-92.
  • Taneja S, Kalra N, Duseja A, Dhiman RK. Noncirrhotic portal fibrosis and abdominal varices. Liver Int. 2010;30:715-7.
  • Puri R, Vilmann P, Sud R, Kumar M, Taneja S, Verma K, Kaushik N. Endoscopic ultrasound-guided fine-needle aspiration cytology in the evaluation of suspected tuberculosis in patients with isolated mediastinal lymphadenopathy. Endoscopy. 2010;42:462-7.
  • Taneja S, Khanna S, Puri R, Saraf N, Sud R. Dual endoscopic therapy for Dieulofoy’s like lesion in duodenal diverticulum: A case report. Journal of Digestive Endoscopy.2010;1:69-72.
  • Taneja S, Kalra N, Dhiman RK, Chawla YK. An abnormal portal vein. Liver Int. 2009 Nov 30. [Epub ahead of print] Taneja S, Das K, Saigal S, Ranjan P, Jain S, Garg N, Malik VK, Arora A. Oesophageal leiomyoma: Case report and review of literature. Trop Gastroenterol. 2007;28:131-2.
  • Taneja S, Das K, Saigal S, Ranjan P, Jain S, Garg N, Malik VK, Arora A. Oesophageal leiomyoma: Case report and review of literature. Trop Gastroenterol. 2007;28:131-2.
  • Mahajan SK, Taneja S, Sharma D, Sharma S. Pulmonary artery aneurysm. The Indian Practitioner 2004; 57:314.
  • SK Mahajan, PC Machan, BR Sood, S Taneja, R Raina, S Thakur, LS Pal. Pitting oedema in Hypothyroidism. JAPI 2003; 51:885.
  • Chawla YK, Taneja Sunil: API Textbook of Medicine Volume 1, 9th Edition 2012 Page No. 885-887, Editor-in-Chief Yash Pal Munjal, Printed at Jaypee Brothers Medical Publishers (P) Ltd, New Delhi.
  • Chawla YK, Sunil Taneja. “Non-Alcoholic Fatty Liver Disease” Edited by Dr. Y.P. Munjal 2011; 1-8. Published by Elsevier Inc. in API Textbook of Medicine.

Registration

  • PUNJAB MEDICAL COUNCIL dated 16th August, 2001, Reg. No. 32375
  • DELHI MEDICAL COUNCIL dated 5th September, 2006, Reg. No. 31675
In this Section